SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 2D 1H-15N HSQC 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
2 2D 1H-13C HSQC 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
3 2D 1H-13C CT-HSQC 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
4 3D CBCA(CO)NH 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
5 3D HNCO 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
6 3D HNCA 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
7 3D C(CO)NH TOCSY 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
8 3D HBHA(CO)NH 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
9 3D H(CCO)NH TOCSY 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
10 3D H(C)CH-TOCSY aliphatic 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
11 3D (H)CCH-TOCSY aliphatic 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
12 3D 15N-NOESY-HSQC 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
13 3D 13C-NOESY-HSQC aliphatic 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
14 3D 13C-NOESY-HSQC aromatic 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
15 3D H(C)CH-TOCSY aromatic 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
16 2D 1H-15N HSQC long range 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
17 2D HBCBCGCDHD 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
18 2D HBCBCGCDCEHE 0.7-1 mM [U-100% 13C; U-100% 15N] protein YBIL-1, 10 uM Zn sulfate-2, 10 mM [U-2H] DTT-3, 10 mM [U-2H] TRIS-4, 300 mM sodium chloride-5, 0.01 % sodium azide-6, 1 mM benzamidine-7, 1 mM Roche inhibitor-8, 90% H2O/10% D2O 0.300 90% H2O/10% D2O 7.0 ambient 298
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
NMR Refinement
Method Details Software
molecular dynamics water bath 1
NMR Ensemble Information
Conformer Selection Criteria structures with the lowest energy
Conformers Calculated Total Number 100
Conformers Submitted Total Number 20
Representative Model 1 (lowest energy)
Computation: NMR Software
# Classification Version Software Name Author
1 refinement ? CNS Brunger, Adams, Clore, Gros, Nilges and Read
2 structure solution ? CYANA Guntert, Mumenthaler and Wuthrich
3 chemical shift assignment ? ABACUS A. Lemak
4 data analysis ? ABACUS A. Lemak
5 geometry optimization ? TALOS Cornilescu, Delaglio and Bax
6 data analysis 2.06 Analysis CCPN
7 peak picking 2.06 Analysis CCPN
8 processing ? NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
9 processing ? MddNMR V. Orekhov, I. Ibraghimov
Feedback Form
Name
Email
Institute
Feedback